The chair of a federal vaccine advisory panel charted a new course for the committee in a podcast released Thursday, questioning longstanding recommendations.
While there are valid scientific discussions that could be held regarding the polio vaccines (the risks and rewards of IPV vs OPV comes immediately to mind), the “concerns” of the people in article are none of those.
While there are valid scientific discussions that could be held regarding the polio vaccines (the risks and rewards of IPV vs OPV comes immediately to mind), the “concerns” of the people in article are none of those.